Clock

What this tab establishes

Devon's re-rating path runs on company-specific self-help, not an industry repricing cycle: $1.0 billion of merger synergies targeted at a year-end-2027 run-rate [1], an $8 billion repurchase authorization against roughly $51 billion of market value [2], and the first full combined quarter printing in November 2026. Devon's own record sets the bar: 15 drawdowns of 35% or deeper since 1990, median round trip 29 months, two never recovered.

The re-rating mechanism

Devon closed an all-stock merger with Coterra Energy on 7 May 2026; each Coterra share converted into 0.70 Devon shares, and Devon survived as the registrant [3]. The mechanisms that could close the gap between today's $44.41 and the street's $59.38 all originate in that transaction and the capital-allocation reset that followed it. Four of them carry dates; one does not.

Synergy capture, on a published schedule. The February 2026 announcement set $1.0 billion of pre-tax synergies at a run-rate by 2027 [4]. The June mid-year update converted that into a dated build: roughly $200 million of run-rate at the 2026 exit, roughly $600 million averaged across 2027, and roughly $980 million at the 2027 exit, split across capital optimization, operating margin and corporate cost [5]. Management restated the target as capturing $600 million during 2027 and reaching the $1.0 billion run-rate by year-end 2027 [6]. Evidence it is in motion: on the Q1 2026 call the integration teams had already identified 156 discrete value-capture items before close, and the CEO described the $1.0 billion as a floor [7]. The prior cycle is the reference: the stand-alone $1.0 billion business-optimization plan announced in April 2025 targeted $1.0 billion of annual pre-tax free cash flow improvement by the end of 2026 [8], and the May 2026 deck marks it 100% complete on stand-alone Q2 2026 guidance, ahead of that deadline [9]. Window: the checkpoints are the Q4 2026 print (2026 exit rate) and the Q4 2027 print (run-rate).

The buyback, shrinking the denominator. Within weeks of close Devon raised the dividend 33% and upsized the repurchase authorization to $8 billion, which it described as 15% of market value [10]. The authorization is a ceiling, not a pace: the same deck sets the annual base at $1.0–$1.5 billion, sustainable through the commodity cycle, with opportunistic upside on top [11]. On 1,153,403,107 shares outstanding at the 18 May 2026 record date [12] and the 29 July close of $44.405, market value is $51.2 billion. That is 1.8 times the $28.1 billion in the run's deterministic feature file, which multiplies the same close by the pre-merger FY2025 share count of 633 million; every ratio scaled by market value on this tab uses the $51.2 billion figure. The base pace retires 2.0%–2.9% of the float a year; the full $8 billion would retire 15.6%. Both numbers matter, and they are two years apart.

Deleveraging and portfolio rationalization. Devon targets retiring $1.25 billion of debt across the remainder of 2026 and roughly $9 billion of gross debt by year-end 2027, holding leverage below 1.0x through the cycle [13]. A complete review of all assets against strategic and financial criteria began at close [14], and the June update says only that Devon will provide updates "at the appropriate time" [15]. No calendar is attached to that review, and the framework's own falsifier applies to it directly: proceeds routed to debt paydown ahead of repurchases would blunt the flywheel described in Self-Help.

What is absent. There is no premium-repricing cycle here, no contract renewal calendar, no regulated rate reset. An exploration-and-production company's revenue reprices continuously with WTI, Henry Hub and NGL differentials, so mean reversion has no scheduled date. Management said as much on the Q1 call: the back end of the curve, not the front, is what they steer by, and they declined to call how the current supply disruption resolves [16]. The Centene-style setup — an industry-wide forecasting error that a repricing round mechanically corrects — is not the setup on this name. That is a difference in kind, not degree.

The dated calendar

Sources: Q2 2026 earnings date from Devon's 1 July 2026 scheduling release [17]; synergy and debt targets from the June 2026 mid-year update [18] [19]. Q3 2026 and Q4 2026 report dates are indicative, projected from Devon's 2025 reporting cadence, and are not company-confirmed; the portfolio-review row carries a placeholder date because no window has been published.

The nearest catalyst is two days out. Devon reports second-quarter 2026 results after the close on Tuesday 4 August 2026, with the call on 5 August [20]. That quarter is a stub: guidance for it reflects legacy Devon plus Coterra only from 7 May [21], so roughly 55 of 91 days are combined. It will also carry a $2.6 billion cash outflow: Devon paid approximately $161,500 per net acre for 16,300 net undeveloped Delaware Basin acres in the 20 May Bureau of Land Management lease sale, funded from cash on hand [22].

Base rates from Devon's own history

The run's daily price file covers 9,211 sessions from 2 January 1990 to 29 July 2026. Running a 30%-reversal zigzag across it isolates 15 completed peak-to-trough legs of 35% or deeper before the current episode began, plus the episode still in progress.

Source: derived from the run's daily close series (9,211 sessions, 1990–2026), data/prices/daily.json; 30%-reversal zigzag, closing prices only, dividends not reinvested. Bars with no upper segment did not regain the prior peak. The 2022-06 episode is the current one and has not recovered.

Source: derived from the run's daily close series, data/prices/daily.json; closing prices only, dividends not reinvested.

The base rates, across the 15 completed episodes:

• Depth. Median −47.2%; range −36.1% to −80.8%. A 40%-plus decline is Devon's normal amplitude, not an outlier.
• Time down. Median 4.9 months from peak to trough; only one episode (1997–98) took longer than seven months.
• Time back. Of the 15, 13 eventually regained the prior peak. Median round trip 29.3 months; median 22.3 months measured from the trough alone. Four of 13 round-tripped inside 18 months (5.9, 7.1, 9.4 and 12.7 months), one more inside 24 months.
• Failures. Two never recovered. The May 2008 peak of $124.36 has not been regained in 18 years; the March 2011 peak of $93.10 has not been regained in 15 years.

The current episode is unusual on one axis and ordinary on the other. Depth: from the 7 June 2022 close of $78.04 to the 8 April 2025 close of $26.80 is −65.7%, deeper than every completed episode except the 2020 collapse. Duration: 34.0 months from peak to trough, against a 4.9-month median — this was a three-year grind, not a crash. As of 29 July 2026 the stock is 15.7 months past that trough, up 65.7% from it, and still 43.1% below the 2022 peak; regaining that peak requires a further 75.7%.

Two qualifications belong here. First, the series is closing prices with no dividends added back, and Devon's payout over this window was large — $3,379 million in FY2022, $1,858 million in FY2023 and $937 million in FY2024, roughly $10 a share across the three years on the then-outstanding count. A total-return drawdown is materially shallower than −65.7%. Second, the deterministic feature file measures the current drawdown from a 31 July 2024 peak of $47.03 rather than the 2022 cycle high, giving −43.0% to the same April 2025 trough; that is the same trough on a shorter lookback window, and both figures are stated here rather than reconciled away. The drawdown anatomy itself belongs to Dislocation.

The 18-month read

Re-recognition to the street's own mark inside 18–24 months is a reasonable expectation; a round trip to the 2022 peak is not underwritable on this name's base rates. The evidence for the first half: every published mechanism lands inside the window — the 2026 synergy exit rate at December 2026, the $1.0 billion run-rate at December 2027, $1.25 billion of debt retired by December 2026, and a repurchase base of $1.0–$1.5 billion a year running continuously from close [23] [24]. Consensus already carries the arithmetic: FY2027 free cash flow of $7.42 billion against a $51.2 billion market value is a 14.5% yield — not the 26.4% the feature file reports on its pre-merger share count — and the mean target of $59.38 sits 33.7% above the 29 July close. The evidence against the second half: the 2022 peak was set at post-invasion oil and gas prices, four of 13 recovered episodes made it back inside 18 months, and two of 15 never made it back at all.

What would falsify the read is the mechanism failing to fire, and it has three named tests, each tied to the falsifier ledger: the 2026 synergy exit rate printing materially below roughly $200 million at the Q4 2026 report; repurchases running under the $1.0 billion annual base; or portfolio-review proceeds and free cash flow routed to debt paydown ahead of buybacks. A fourth sits outside management's control — a commodity path that undoes the cash flows underneath all of it.

What consensus expects, and when

Source: consensus estimate data as of 29 July 2026 (26 contributing targets); last close from the run's daily price series.

The sell side has not capitulated. Across 27 in-consensus opinions there are 21 buy and 4 outperform ratings against 2 hold, no sell and no underperform, for a consensus recommendation score of 1.30 on a scale where 1 is the most positive. The lowest published target, $44, is essentially the current price — no contributor carries a target implying material downside. The framework's entry condition is peak fear, and the analyst body is not expressing it. That cuts against fit on this criterion regardless of what the price has done.

Estimate momentum complicates the picture in both directions. FY2027 revenue consensus moved from $15.78 billion 180 days ago to $26.62 billion now as the merger entered the numbers, and FY2027 EPS from $4.71 to $5.24. But the near-term direction turned down in the last month: FY2027 revenue stood at $28.91 billion 30 days ago and EPS at $5.48, so the past 30 days took 7.9% off revenue and 4.4% off EPS. Guidance is not resetting against a low bar; estimates are being trimmed off a recent high, ahead of a print.

Source: consensus quarterly estimates as of 29 July 2026; figures for 3Q24 through 1Q26 are the consensus means standing before each print, not reported actuals.

Consensus expects the recovery to show up in printed numbers on a specific schedule. Quarterly free cash flow runs $521–$911 million through the stand-alone period, steps to $1,585 million in 2Q26, and reaches $1,935 million by 4Q26 and $2,178 million by 1Q27. EBITDA roughly doubles at the same seam, from $1,942 million in 1Q26 to $3,378 million in 2Q26.

The candidate quarter is the third of 2026, reported in early November. Second-quarter 2026, printing 4 August, is a stub with under two months of Coterra and a $2.6 billion acreage payment inside it — a hard quarter to read cleanly. The third quarter is the first with three full combined months, the first with a full quarter of repurchases under the new authorization, and the first at which the roughly $200 million 2026 synergy exit rate can be checked against a partial-year print. Fourth-quarter 2026, reported in February 2027, is where the exit rate itself is verifiable.

Instrument facts

These are facts about listed instruments, recorded as facts. Nothing here is a recommendation, and no strike or expiry is named as a choice.

• Long-dated listed options exist. Cboe delayed options quotes for DVN, timestamped 1 August 2026, list 14 expiries running from 7 August 2026 to 15 December 2028. Two clear twelve months: 21 January 2028, 537 days out (17.6 months), and 15 December 2028, 866 days out (28.4 months). Each carries 42 listed strikes.
• Open interest. Total open interest across all listed expiries is approximately 517,000 contracts. At the January 2028 expiry it is 20,715 contracts; at the December 2028 expiry, 8,595 contracts. For scale, the September 2026 and August 2026 monthly expiries carry roughly 119,000 and 122,000 contracts respectively. Long-dated open interest is therefore present but thin relative to the front of the curve — under 6% of the total sits beyond twelve months.
• Implied volatility. AlphaQuery reports DVN 30-day mean implied volatility of 41.5% and 180-day mean implied volatility of 38.4%, both as of 31 July 2026. In the Cboe file, at-the-money implied volatility is approximately 37.6% at the January 2028 expiry and approximately 38.3% at December 2028; the 7 August weekly prints near 50%, reflecting the 4 August earnings date. Against the framework's reference lines — up to roughly 50–55 acceptable, 60–70 elevated — the long-dated level sits below the acceptable band, and the elevated front-week reading is an earnings artefact that decays within the week.

The framework's watchlist-only case, which applies when no qualifying long-dated options exist, does not apply to Devon.